HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE

70 Ratings

Rs 8,580 Rs 6,500

24 % OFF

THIS TEST IDENTIFIES GENETIC MUTATIONS IN MYCOBACTERIUM TUBERCULOSIS THAT CONFER RESISTANCE TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS SUCH AS ISONIAZID AND RIFAMPICIN. ITS CLINICAL SIGNIFICANCE IS TO GUIDE THE INITIAL TREATMENT PLAN FOR PATIENTS WITH TUBERCULOSIS (TB) BY DETERMINING IF THE STANDARD FIRST-LINE DRUGS WILL BE EFFECTIVE OR IF A DIFFERENT REGIMEN IS NEEDED DUE TO DRUG RESISTANCE.

Related Test/Package

-26%

Electrolytes, Serum

167 Ratings

Rs 500 Rs 675

-24%

Calcium, Serum (ca)

105 Ratings

HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE

Rs 8,580 Rs 6,500

24 % OFF

Why book with us?

Get a Free Call

HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE

Rs 8,580 Rs 6,500

24 % OFF

Why book with us?

Related Test/Package

Rs 500 Rs 675

Rs 130 Rs 176

Rs 540 Rs 724

Rs 800 Rs 1,064

Rs 360 Rs 468

Rs 200 Rs 264

Rs 500 Rs 650

Rs 50 Rs 66

Rs 700 Rs 945

Rs 7,500 Rs 10,050

Get a Free Call